The DOI matches its Crossref record; 95 of the 97 references it cites were found in a registry or an index.
DIAGNOSIS OF ENDOCRINE DISEASE: Differentiation of pathologic/neoplastic hypercortisolism (Cushing’s syndrome) from physiologic/non-neoplastic hypercortisolism (formerly known as pseudo-Cushing’s syndrome)
Abstract
Endogenous hypercortisolism (Cushing’s syndrome) usually implies the presence of a pathologic condition caused by either an ACTH-secreting neoplasm or autonomous cortisol secretion from a benign or malignant adrenal neoplasm. However, sustained or intermittent hypercortisolism may also accompany many medical disorders that stimulate physiologic/non-neoplastic activation of the HPA axis (formerly known as pseudo-Cushing’s syndrome); these two entities may share indistinguishable clinical and biochemical features. A thorough history and physical examination is often the best (and sometimes only) way to exclude pathologic/neoplastic hypercortisolism. The presence of alcoholism, renal failure, poorly controlled diabetes and severe neuropsychiatric disorders should always raise suspicion that the presence of hypercortisolism may be related to physiologic/non-neoplastic Cushing’s syndrome. As late-night salivary cortisol and low-dose dexamethasone suppression have good sensitivity and negative predictive value, normal studies exclude Cushing’s syndrome of any form. However, these tests have imperfect specificity and additional testing over time with clinical follow-up is often needed. When there is persistent diagnostic uncertainty, secondary tests such as the DDAVP stimulation test and the dexamethasone-CRH test may provide evidence for the presence or absence of an ACTH-secreting tumor. This review will define and characterize the numerous causes of physiologic/non-neoplastic hypercortisolism and provide a rational clinical and biochemical approach to distinguish it from pathologic/neoplastic hypercortisolism (true Cushing’s syndrome).
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This argues that complementary tests of adrenal function are required to establish the diagnosis but that a patient with a normal result is unlikely to have ACTH-dependent CS [61].”
From Prospective Evaluation of Late-Night Salivary Cortisol and Cortisone by EIA and LC-MS/MS in Suspected Cushing Syndrome (2020) · cites this paper as [61]
In the citing paper
“many nonneoplastic forms of hypercortisolism, such as chronic kidney disease stage 5 and alcohol abuse disorder may also be associated with elevations of LNSC [61, 77]”
From Prospective Evaluation of Late-Night Salivary Cortisol and Cortisone by EIA and LC-MS/MS in Suspected Cushing Syndrome (2020) · cites this paper as [61]
In the citing paper
“Pseudo-CS, or nonneoplastic physiologic hypercortisolism, is a phenomenon that can occur in many medical disorders such as chronic alcoholism, chronic kidney disease, type 2 diabetes mellitus, and psychiatric conditions.”
From Approach to the Patient: Diagnosis of Cushing Syndrome (2022) · cites this paper as [56]
In the citing paper
“Over time, the effects of small increases in cortisol can lead to significant and longitudinal glucocorticoid exposure and can result in pathologic features of hypercortisolism as is also illustrated in case 1 (1, 56, 57).”
From Approach to the Patient: Diagnosis of Cushing Syndrome (2022) · cites this paper as [56]
In the citing paper
“There is also decreased sensitivity to glucocorticoid negative feedback in the majority of these states which may lead to mild increases in cortisol.”
From Approach to the Patient: Diagnosis of Cushing Syndrome (2022) · cites this paper as [56]
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
The diagnosis of Cushing's syndrome: an Endocrine Society Clinical Practice Guideline.
Nieman, L. K., Biller, B. M. K., Findling, J. W., Newell-Price, J., Savage, M. O., Stewart, P. M., & Montori, V. M. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-0125 · Cited by 2,718
Self-citationThe HPA axis in major depression: classical theories and new developments
Pariante, C. M., & Lightman, S. L. (2008) · Trends in Neurosciences · doi:10.1016/j.tins.2008.06.006 · Cited by 2,009
Regulation of the Hypothalamic‐Pituitary‐Adrenocortical Stress Response
Herman, J. P., McKlveen, J. M., Ghosal, S., Kopp, B., Wulsin, A., Makinson, R., Scheimann, J., & Myers, B. (2016) · Comprehensive Physiology · doi:10.1002/cphy.c150015 · Cited by 1,819
Silverman, M. N., & Sternberg, E. M. (2012) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2012.06633.x · Cited by 731
Hall, W. A., Luciano, M. G., Doppman, J. L., Patronas, N. J., & Oldfield, E. H. (1994) · Annals of Internal Medicine · doi:10.7326/0003-4819-120-10-199405150-00001 · Cited by 627
Acute Hypothalamic–Pituitary–Adrenal Responses to the Stress of Treadmill Exercise
Luger, A., Deuster, P. A., Kyle, S. B., Gallucci, W. T., Montgomery, L. C., Gold, P. W., Loriaux, D. L., & Chrousos, G. P. (1987) · New England Journal of Medicine · doi:10.1056/nejm198705213162105 · Cited by 516
HIGH AST/ALT RATIO MAY INDICATE ADVANCED ALCOHOLIC LIVER DISEASE RATHER THAN HEAVY DRINKING
NYBLOM, H. (2004) · Alcohol and Alcoholism · doi:10.1093/alcalc/agh074 · Cited by 474
Abnormal Hypothalamic–Pituitary–Adrenal Function in Anorexia Nervosa
Gold, P. W., Gwirtsman, H., Avgerinos, P. C., Nieman, L. K., Gallucci, W. T., Kaye, W., Jimerson, D., Ebert, M., Rittmaster, R., Loriaux, D. L., et al. (1986) · New England Journal of Medicine · doi:10.1056/nejm198605223142102 · Cited by 454
The hypothalamic-pituitary-adrenal axis in pregnancy: challenges in disease detection and treatment
Lindsay, J. R., & Nieman, L. K. (2005) · Endocrine Reviews · doi:10.1210/er.2004-0025 · Cited by 449
A longitudinal study of plasma and urinary cortisol in pregnancy and postpartum
Jung, C., Ho, J. T., Torpy, D. J., Rogers, A., Doogue, M., Lewis, J. G., Czajko, R. J., & Inder, W. J. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-2395 · Cited by 394
Research works printed but not linked: 8
- 10.1210/jc.77.2.518 · doi:10.1210/jc.77.2.518
- 10.1001/jama.1979.03300150038024 · doi:10.1001/jama.1979.03300150038024
- 10.1111/j.1530-0277.2000.tb02036.x · doi:10.1111/j.1530-0277.2000.tb02036.x · Paper page
- 10.1111/j.1530-0277.2001.tb02268.x · doi:10.1111/j.1530-0277.2001.tb02268.x · Paper page
- Androulakis II Kaltsas G & Chrousos. Pseudo-Cushing’s states. In Endotext. Eds De Groot LJ Chrousos G Dungan K Grossman A Hershman JM Koch C Korbonits M McLachlan R New M Purnell J Rebar R Singer F Vinik A South Dartmouth, MA 2000. MDText.com, Inc.; 2000. Available from: https://www.ncbi.nlm.nih.gov/books/NBK279081/
- 10.1210/jc.77.2.503 · doi:10.1210/jc.77.2.503
- 10.1210/jc.81.6.2233 · doi:10.1210/jc.81.6.2233
- 10.1210/jc.85.10.3569 · DOI
Cited by
Consensus on diagnosis and management of Cushing's disease: a guideline update
Fleseriu, M., Auchus, R., Bancos, I., Ben-Shlomo, A., Bertherat, J., Biermasz, N. R., Boguszewski, C. L., Bronstein, M. D., Buchfelder, M., Carmichael, J. D., et al. (2021) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(21)00235-7 · Cited by 953
“53 We recommend considering the patient’s clinical history, particularly the duration of symptoms, and repeating tests to avoid implementing inappropriate treatment if Cushing’s syndrome is not present (low quality, discretionary recommendation).”
Self-citationReincke, M., & Fleseriu, M. (2023) · JAMA · doi:10.1001/jama.2023.11305 · Cited by 256
Medical Treatment of Cushing's Disease: An Overview of the Current and Recent Clinical Trials
Pivonello, R., Ferrigno, R., Martino, M. C. D., Simeoli, C., Paola, N. D., Pivonello, C., Barba, L., Negri, M., de Angelis, C., & Colao, A. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00648 · Cited by 146
Approach to the Patient: Diagnosis of Cushing Syndrome
Savas, M., Mehta, S., Agrawal, N., van Rossum, E. F. C., & Feelders, R. A. (2022) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgac492 · Cited by 91
“However, if there is diagnostic uncertainty, a 48-hour 2 mg/d DST or secondary tests can be performed, including DDAVP stimulation, and dexamethasone-CRH testing (1, 3, 56-58).”
BackgroundMethodVassiliadi, D. A., & Tsagarakis, S. (2018) · European Journal of Endocrinology · doi:10.1530/eje-18-0007 · Cited by 78
Metadata
- Authors
- Findling, J. W., & Raff, H.
- Affiliations
- Medical College of Wisconsin (US)
- Corresponding author
- Findling, James W
- Venue
- European Journal of Endocrinology
- Publisher
- Oxford University Press (OUP)
- Published
- 2017-05
- Volume
- 176
- Issue
- 5
- Pages
- R205-R216
- ISSN
- 0804-4643 (ISSN-L)
- 1479-683X
- OpenAlex
- W2586798222
- Cited by
- 134
- References
- 97
- Citations by year
- 2026: 12 · 2025: 9 · 2024: 12 · 2023: 12 · 2022: 18 · 2021: 18 · 2020: 20 · 2019: 16 · 2018: 13 · 2017: 3
- FWCI
- 11.25
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- European Journal of Endocrinology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pituitary Gland Disorders and Treatments
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Health Sciences › Medicine › Surgery › Adrenal and Paraganglionic Tumors
- Keywords
- Cushing's syndrome, pseudo-Cushing's syndrome, hypercortisolism, HPA axis activation, adrenal tumors, late-night salivary cortisol, diagnostic workup, alcoholism, renal failure, diabetes mellitus
- MeSH terms
- Animals, Cushing Syndrome, Endocrine System Diseases, Humans, Hydrocortisone
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: DIAGNOSIS OF ENDOCRINE DISEASE: Differentiation of pathologic/neoplastic hypercortisolism (Cushing’s syndrome) from physiologic/non-neoplastic hypercortisolism (formerly known as pseudo-Cushing’s syndrome). https://app.cochat.ai/papers/10.1530/eje-16-0946
- The paper
- Findling, J. W., & Raff, H. (2017). DIAGNOSIS OF ENDOCRINE DISEASE: Differentiation of pathologic/neoplastic hypercortisolism (Cushing’s syndrome) from physiologic/non-neoplastic hypercortisolism (formerly known as pseudo-Cushing’s syndrome). European Journal of Endocrinology. https://doi.org/10.1530/eje-16-0946
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.